Lymphocyte subsets in healthy children from birth through 18 years of age: The pediatric AIDS clinical trials group P1009 study

被引:653
|
作者
Shearer, WT
Rosenblatt, HM
Gelman, RS
Oymopito, R
Plaeger, S
Stiehm, ER
Wara, DW
Douglas, SD
Luzuriaga, K
McFarland, EJ
Yogev, R
Rathore, MH
Levy, W
Graham, BL
Spector, SA
机构
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] NIAID, Bethesda, MD 20892 USA
[5] Univ Calif Los Angeles, Los Angeles, CA USA
[6] Univ Calif San Francisco, San Francisco, CA 94143 USA
[7] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[8] Univ Massachusetts, Worcester, MA 01003 USA
[9] Univ Colorado, Ctr Hlth Sci, Denver, CO 80202 USA
[10] Childrens Mem Hosp, Chicago, IL 60614 USA
[11] Univ Florida, Ctr Hlth Sci, Jacksonville, FL USA
[12] Univ Calif San Diego, San Diego, CA 92103 USA
关键词
lymphocyte subsets; 3-colorflow cytometry; infants; children; adolescents; healthy control subjects;
D O I
10.1016/j.jaci.2003.07.003
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Peripheral blood lymphocyte subsets need to be determined in a large, urban, minority-predominant cohort of healthy children to serve as suitable control subjects for the interpretation of the appearance of these cells in several disease conditions, notably pediatric HIV-1 infection. Objective: We sought to determine the distribution of lymphocyte subsets in healthy urban-dwelling infants, children, and adolescents in the United States. Methods: Lymphocyte subsets were determined by means of 3-color flow cytometry in a cross-sectional study of 807 HIV-unexposed children from birth through 18 years of age. Results: Cell-surface marker analysis demonstrated that age was an extremely important variable in 24 lymphocyte subset distributions measured as percentages or absolute counts-eg, the CD4 (helper) T cell, CD8 (cytotoxic) T cell, CD19 B cell, CD4CD45RACD62L (naive helper) T cell, CD3CD4CD45RO (memory helper) T cell, CD8HLA-DRCD38 (activated cytotoxic) T cell, and CD8CD28 (activation primed cytotoxic) T cell. The testing laboratory proved to be an important variable, indicating the need for using the same laboratory or group of laboratories to assay an individual's blood over time and to assay control and ill or treated populations. Sex and race-ethnicity were much less important. Conclusion: The results of this study provide a control population for assessment of the effects of HIV infection on the normal development and distribution of lymphocyte subsets in children of both sexes, all races, and all ethnic backgrounds from birth through 18 years of age in an urban population. This study's findings will also prove invaluable in interpreting the immune changes in children with many other chronic diseases, such as primary immunodeficiency, malignancy, rheumatoid arthritis, and asthma.
引用
收藏
页码:973 / 980
页数:8
相关论文
共 3 条
  • [1] Characteristics of lymphocyte subsets in HIV-infected, long-term nonprogressor, and healthy Asian children through 12 years of age
    Ananworanich, Jintanat
    Apornpong, Tanakorn
    Kosalaraksa, Pope
    Jaimulwong, Tanyathip
    Hansudewechakul, Rawiwan
    Pancharoen, Chitsanu
    Bunupuradah, Torsak
    Chandara, Mom
    Puthanakit, Thanyawee
    Ngampiyasakul, Chaiwat
    Wongsawat, Jurai
    Kanjanavanit, Suparat
    Luesomboon, Wicharn
    Klangsinsirikul, Phennapha
    Ngo-Giang-Huong, Nicole
    Kerr, Stephen J.
    Ubolyam, Sasiwimol
    Mengthaisong, Tawan
    Gelman, Rebecca S.
    Pattanapanyasat, Kovit
    Saphonn, Vonthanak
    Ruxrungtham, Kiat
    Shearer, William T.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 126 (06) : 1294 - U352
  • [2] Prevalence of elevated cholesterol and associated risk factors among perinatally HIV-infected children (4-19 years old) in pediatric AIDS clinical trials group 219C
    Farley, J
    Gona, P
    Crain, M
    Cervia, J
    Oleske, J
    Seage, G
    Lindsey, J
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 38 (04) : 480 - 487
  • [3] A Randomized, Double-blind, Active-controlled Clinical Trial of a Cell Culture-derived Inactivated Trivalent Influenza Vaccine (NBP607) in Healthy Children 6 Months Through 18 Years of Age
    Oh, Chi Eun
    Choi, Ui-Yoon
    Eun, Byung Wook
    Lee, Taek Jin
    Kim, Ki Hwan
    Kim, Dong Ho
    Kim, Nam Hee
    Jo, Dae Sun
    Shin, Sun Hee
    Kim, Kyung-Ho
    Kim, Hun
    Kim, Yun-Kyung
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2018, 37 (06) : 605 - 611